Riyadh – Mubasher: Twareat Medical Care Company announced that its ordinary general assembly approved the appointment of Dr. Mohamed Al-Amri & Co. as the external auditor.
The firm will review and audit financial statements for the second (Q2) and third (Q3) quarters of 2026, the annual period ending on 31 December 2026 and Q1-27 for a total fee of SAR 530,000 excluding VAT.
The meeting, , held on 30 June 2026, also resulted in shareholders authorizing the board of directors to distribute interim dividends on a semi-annual or quarterly basis for the 2026 fiscal year.
Furthermore, the assembly approved related-party transactions with Urgent Care Pharmacy Company, involving the sale and purchase of medical supplies and equipment.
These transactions have an expected annual value of SAR 1 million, following dealings totaling SAR 87,347 in the previous year.
Additional approvals included the discharge of board members for the 2025 fiscal year and the adoption of a credit risk and expected credit loss allowance policy.
Shareholders also ratified amendments to the remuneration policy for the board, its committees, and executive management.
